Ibrahim-Kosta Manal, El Harake Sarah, Leclercq Barbara, De Mari Céline, Secondi Jean-François, Paoletti Emilie, Suchon Pierre, Benredouane Yasmine, Brunet Dominique, Barthet Marie-Christine, Bruzelius Maria, Munsch Gaëlle, Trégouët David-Alexandre, Morange Pierre-Emmanuel, Goumidi Louisa, Sarlon-Bartoli Gabrielle
Hematology Laboratory, La Timone University Hospital of Marseille, Aix-Marseille University, INSERM 1263, INRAE 1260, C2VN, Marseille, France; Service d'hématologie, Faculté de Médecine de Marseille, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone, Marseille, France.
Service de médecine vasculaire et Hypertension Artérielle, Faculté de Médecine de Marseille, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone, Marseille, France.
J Thromb Haemost. 2025 Mar;23(3):937-946. doi: 10.1016/j.jtha.2024.09.039. Epub 2024 Oct 31.
The long-term recurrence risk after a pregnancy-associated venous thromboembolism (VTE) is sparsely assessed.
To determine the rate of recurrence after a pregnancy-associated VTE and identify associated risk factors.
Five hundred eighty-seven women with a history of first VTE occurring during pregnancy or up to 3 months after delivery were referred to La Timone Hospital, Marseille, France. Women were consecutively included between 2000 and 2015. VTE characteristics and biological parameters were collected upon inclusion. During the 2016-2019 period, patients were recontacted to gather information on postinclusion VTE. A weighted Cox model, adapted to the study's ambispective design, was used to analyze pre- and postinclusion VTE recurrences.
After quality controls, 583 women were analyzed. The incidence of recurrent VTE was 2.4% person-years. The cumulative risk of VTE recurrence was 38% (n = 221), with a median follow-up of 31 years (95% CI: 27-35); 6%, 13%, 17%, and 30% at 2, 5, 10, and 30 years respectively. Pulmonary embolism at first event was associated with a 2-fold increased risk of pulmonary embolism at recurrence compared with isolated deep venous thrombosis (DVT, hazard ratio [HR]: 2.63; 95% CI: 1.44-4.82). Risk factors significantly associated with recurrence were interrupted pregnancies (HR: 1.85; 95% CI: 1.18-2.90), lower limb DVT (HR: 2.95; 95% CI: 1.16-7.49), and AB blood group (HR: 1.71; 95% CI: 1.06-2.77).
Although the recurrence risk is low within the first 10 years after a pregnancy-associated VTE, one-third of patients experienced a new event over a 30-year period. Interrupted pregnancies, lower limb DVT, and AB blood group were associated with higher risk of recurrence.
妊娠相关静脉血栓栓塞症(VTE)后的长期复发风险评估较少。
确定妊娠相关VTE后的复发率,并识别相关危险因素。
587名在孕期或产后3个月内首次发生VTE的女性被转诊至法国马赛的拉蒂莫内医院。2000年至2015年期间连续纳入女性。纳入时收集VTE特征和生物学参数。在2016 - 2019年期间,再次联系患者以收集纳入后VTE的信息。采用适用于该研究前瞻性设计的加权Cox模型分析纳入前后的VTE复发情况。
经过质量控制后,分析了583名女性。VTE复发的发生率为2.4%人年。VTE复发的累积风险为38%(n = 221),中位随访时间为31年(95% CI:27 - 35);2年、5年、10年和30年时分别为6%、13%、17%和30%。首次事件为肺栓塞与复发时肺栓塞风险增加2倍相关,而孤立性深静脉血栓形成(DVT)则不然(风险比[HR]:2.63;95% CI:1.44 - 4.82)。与复发显著相关的危险因素为妊娠中断(HR:1.85;95% CI:1.18 - 2.90)、下肢DVT(HR:2.95;95% CI:1.16 - 7.49)和AB血型(HR:1.71;95% CI:1.06 - 2.77)。
尽管妊娠相关VTE后10年内复发风险较低,但三分之一的患者在30年期间经历了新的事件。妊娠中断、下肢DVT和AB血型与较高的复发风险相关。